UNICA IRIS Institutional Research Information System

DEIDDA, MARTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 145.096
NA - Nord America 6.004
AS - Asia 637
OC - Oceania 17
SA - Sud America 11
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 151.772
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 143.756
US - Stati Uniti d'America 5.952
CN - Cina 492
UA - Ucraina 457
SE - Svezia 407
GB - Regno Unito 143
FI - Finlandia 129
DE - Germania 111
VN - Vietnam 64
CA - Canada 40
SG - Singapore 36
FR - Francia 29
BE - Belgio 20
AU - Australia 15
RU - Federazione Russa 13
IN - India 11
IR - Iran 9
BR - Brasile 7
MX - Messico 6
RS - Serbia 6
NL - Olanda 5
PL - Polonia 5
CH - Svizzera 4
KR - Corea 4
PR - Porto Rico 4
TR - Turchia 4
ZA - Sudafrica 4
JP - Giappone 3
CL - Cile 2
CU - Cuba 2
GR - Grecia 2
HK - Hong Kong 2
ID - Indonesia 2
IE - Irlanda 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PH - Filippine 2
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
NO - Norvegia 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 151.772
Salva come PNG Salva come JPEG
Città #
Cagliari 143.430
Fairfield 909
Woodbridge 727
Houston 507
Ashburn 415
Chandler 406
Wilmington 396
Ann Arbor 390
Seattle 346
Nyköping 343
Cambridge 316
Jacksonville 245
Dearborn 210
Nanjing 98
Boston 84
Beijing 81
Boardman 81
Dong Ket 64
Helsinki 59
San Diego 55
Redwood City 50
Shanghai 44
New York 38
Shenyang 36
Nanchang 31
London 28
Hebei 26
Toronto 25
Guangzhou 22
Milan 21
Mountain View 19
Tianjin 19
Jiaxing 17
Norwalk 16
Brussels 15
Jinan 15
Phoenix 15
Atlanta 14
Changsha 14
Auburn Hills 13
Zhengzhou 13
Kunming 12
Quartu Sant'elena 12
Falls Church 10
Hefei 10
Orange 10
Washington 9
Augusta 8
Borås 8
Genova 8
San Mateo 8
Sestu 8
Sassari 7
Detroit 6
Duncan 6
Los Angeles 6
Saint Petersburg 6
Wuhan 6
Leawood 5
Monmouth Junction 5
Ningbo 5
Verona 5
Ardabil 4
Chicago 4
Fuzhou 4
New Bedfont 4
Pune 4
Redmond 4
Rome 4
Chiswick 3
Hounslow 3
Kilburn 3
Nanning 3
Pordenone 3
Quzhou 3
Shaoxing 3
Skopanie 3
Tempe 3
Walnut 3
Xian 3
Afragola 2
Amsterdam 2
Belleville 2
Biella 2
Capannori 2
Cape Town 2
Carolina 2
Chengdu 2
Chiampo 2
Chongqing 2
Christchurch 2
Collegno 2
Ecatepec 2
Edinburgh 2
Geneve 2
Gonnesa 2
Hangzhou 2
Hong Kong 2
Indiana 2
Islington 2
Totale 149.914
Salva come PNG Salva come JPEG
Nome #
Metabolomic approach to profile functional and metabolic changes in heart failure 3.913
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.564
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.500
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.181
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.123
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 2.966
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 2.949
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 2.866
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.811
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 2.799
Metabolomics and heart failure: a new and promising scientific approach 2.659
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 2.655
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine 2.623
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 2.577
Coronary Artery Disease 2.549
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.489
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.468
Metabolomics, a promising approach to translational research in cardiology 2.399
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.146
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.080
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.034
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 1.958
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 1.939
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 1.927
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 1.920
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 1.918
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 1.891
IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study 1.832
The need of a gender-corrected evidence based medicine 1.821
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? 1.813
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 1.813
Women-specific predictors of cardiovascular disease risk - new paradigms 1.795
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 1.784
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 1.767
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 1.759
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 1.707
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 1.703
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 1.702
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.693
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.643
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 1.602
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.598
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.562
Gender differences in cardiology: is it time for new guidelines? 1.535
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 1.495
null 1.489
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.488
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.483
null 1.471
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.427
Ankle-brachial index and its link to automated carotid ultrasound measurement of intima-media thickness variability in 500 Japanese coronary artery disease patients 1.410
Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs 1.396
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.396
Association of automated carotid IMT measurement and HbA1c in Japanese patients with coronary artery disease 1.389
Gender-specific aspects in primary and secondary prevention of cardiovascular disease 1.377
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.335
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.293
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 1.282
Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue? 1.268
null 1.234
Vascular damage-Coronary artery disease 1.195
Metabolomics: a new era in cardiology? 1.172
Sex differences in congenital heart defects and genetically induced arrhythmias 1.158
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 1.142
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects 1.126
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.076
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.022
Relationship between high values of HOMA-IR and cardiovascular response to metformin 984
null 944
Early Ventricular Dysfunction in Type II Diabetes: Role of Metabolic Unbalance 939
Looking for the gender equality 925
Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients 921
Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection 887
Altered transmural contractility in women affected by cardiac X syndrome 804
Metabolomic approach to foetal and neonatal heart 789
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 785
null 745
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 648
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 572
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 563
Contribution of metabolomics to the understanding of nafld and nash syndromes: A systematic review 560
Subclinical contractility impairment in HIV-infected patients: dependence on the class of antiretroviral drugs 541
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 525
Gender determinants of cardiovascular risk factors and diseases 511
A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics 503
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 475
Subclinical contractility impairment in HIV-infected patients varies according to class of antiretroviral drugs 468
Cardiac effects of L-thyroxine administration in borderline hypothyroidism 463
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 453
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 437
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 434
Impairment of physical exercise capacity in healthy postmenopausal women 434
null 431
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study 427
Effect of hormone therapy on exercise capacity in early postmenopausal women 420
Early contractility impairment during anthracycline treatment revealed by serial tissue Doppler echocardiography in presence of negative biochemical markers 413
The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy 402
La Metabolomica: una nuova era in Cardiologia. Le nostre esperienze originali nei campi dell' insufficienza cardiaca, della cardiopatia ischemica e dell' ipertensione polmonare 397
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk 393
Cardiac function in borderline hypothyroidism: a study by pulsed wave tissue Doppler imaging 393
Totale 148.743
Salva come PNG Salva come JPEG
Categoria #
all - tutte 179.010
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.010
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.209 0 0 0 0 0 0 0 0 0 0 669 540
2019/202027.527 1.347 834 163 461 9.908 7.117 3.898 833 534 611 670 1.151
2020/202142.441 1.309 1.750 1.665 11.162 8.807 4.724 3.140 2.759 1.149 2.344 2.129 1.503
2021/20229.104 1.063 579 467 814 717 670 456 511 947 845 1.006 1.029
2022/202313.092 1.267 2.022 1.775 1.157 1.140 1.093 566 849 819 765 1.039 600
2023/202411.986 724 547 614 968 1.426 2.452 2.357 919 978 938 63 0
Totale 152.186